Rating History for Theravance Biopharma (TBPH) by BTIG
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/29/2026 | Julian Harrison | Downgrade | Neutral (Buy) |
N/A (N/A) |
17.63 (16.93) |
-3.97% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/29/2026 | Julian Harrison | Downgrade | Neutral (Buy) |
N/A (N/A) |
17.63 (16.93) |
-3.97% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||